Bayer Appeals India Patent Ruling on Drug License
Germany’s Bayer AG has appealed against the grant of a compulsory license by India’s patent authority to a local generic drug producer for its kidney- and liver-cancer medicine, Nexavar (sorafenib).
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.